Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Kidney Disease, Chronic: early-phase trial registry
4 of 8 indexed Kidney Disease, Chronic trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,176 of 28,707 conditions by registered trial count.
8 US clinical trials · 4 currently recruiting · #2,176 of 28,707 conditions by registered trial count
Kidney Disease, Chronic: 8 US clinical trials tracked, 4 recruiting.
Kidney Disease, Chronic is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Rutgers, The State University of New Jersey, running 2 of these trials.
Enrollment posture brief
Registry condition kidney-disease-chronic
OPEN 4 | RECR 50% | LATE 1 | EARLY 3 | RANK #2176 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Kidney Disease, Chronic lists 4 open slots (50% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Kidney Disease, Chronic on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Kidney Disease, Chronic is recruiting above its size-band peers.
4 of 8 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Kidney Disease, Chronic research.
Rutgers, The State University of New Jersey accounts for 2 of 8 trials (25%). 7 distinct sponsors appear on at least one study for this condition label.
-
Most Kidney Disease, Chronic trials plan to enrol fewer than 100 people.
Median target enrolment is 62 among the 8 trials that report a genuine target (sentinel values excluded). 5 of those (62.5%) plan for fewer than 100 participants.
-
Kidney Disease, Chronic research is mostly interventional.
6 interventional and 2 observational studies make up this index (75% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
8 total, page 1 of 1
Rutgers University Study of the Genetics of Kidney Disease
Rutgers, The State University of New Jersey
NCT07217535
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Boehringer Ingelheim
NCT06531824
APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO)
Wake Forest University Health Sciences
NCT03615235
Testosterone Treatment in Men with Chronic Kidney Disease
St. Louis University
NCT05249634
Food is Medicine vs Lifestyle Medicine For Cardiovascular Kidney Metabolic (CKM) Syndrome
Rutgers, The State University of New Jersey
NCT06461273
Plant-based Diet for Kidney Transplant Recipients
George Washington University
NCT06186843
Safety, Tolerability, and Feasibility of Empagliflozin Therapy in Dialysis-dependent ESKD
University of Utah
NCT05614115
Drug-gene-nutraceutical Interactions of Cannabidiol and Tacrolimus
Indiana University
NCT05490511
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 1 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Kidney Disease, Chronic records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Kidney Disease, Chronic trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Kidney Disease, Chronic page
8 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Kidney Disease, Chronic trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Rutgers, The State University of New Jersey sponsors the most Kidney Disease, Chronic trials on record, review their full trial history before evaluating a specific study. See Rutgers, The State University of New Jersey's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Kidney Disease, Chronic condition card totals 8 registered trials; most-linked intervention Empagliflozin; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.